Loading...
Keytruda (Pembrolizumab): First PD-1 Inhibitor Approved for Previously Treated Unresectable or Metastatic Melanoma
Saved in:
| Published in: | Am Health Drug Benefits |
|---|---|
| Main Author: | |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Engage Healthcare Communications, LLC
2015
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4665064/ https://ncbi.nlm.nih.gov/pubmed/26629272 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|